Antiviral Therapy Utilization and 10-Year Outcomes in Resected Hepatitis B Virus- and Hepatitis C Virus-Related Hepatocellular Carcinoma

• Published in: Journal of clinical oncology Vol. 42; no. 7; pp. 790 - 799
• Main Authors: Huang, Daniel Q, Hoang, Joseph K, Kamal, Rubayet, Tsai, Pei-Chien, Toyoda, Hidenori, Yeh, Ming-Lun, Yasuda, Satoshi, Leong, Jennifer, Maeda, Mayumi, Huang, Chung-Feng, Won Jun, Dae, Ishigami, Masatoshi, Tanaka, Yasuhito, Uojima, Haruki, Ogawa, Eiichi, Abe, Hiroshi, Hsu, Yao-Chun, Tseng, Cheng-Hao, Alsudaney, Manaf, Yang, Ju Dong, Yoshimaru, Yoko, Suzuki, Takanori, Liu, Joanne K, Landis, Charles, Dai, Chia-Yen, Huang, Jee-Fu, Chuang, Wan-Long, Schwartz, Myron, Dan, Yock Young, Esquivel, Carlos, Bonham, Andrew, Yu, Ming-Lung, Nguyen, Mindie H
• Format: Journal Article
• Language: English
• Published: United States 01.03.2024
• Subjects: Aged; Antiviral Agents - therapeutic use; Carcinoma, Hepatocellular - pathology; Cohort Studies; Female; Hepacivirus; Hepatitis B - complications; Hepatitis B - drug therapy; Hepatitis B virus; Hepatitis C - complications; Hepatitis C - drug therapy; Humans; Liver Neoplasms - pathology; Male; Middle Aged; Retrospective Studies

There are limited data on antiviral treatment and its impact on long-term outcomes of hepatitis B virus (HBV)- and hepatitis C virus (HCV)-related hepatocellular carcinoma (HCC) after hepatic resection. We aimed to determine the and impact of antivirals in HBV- and HCV-related HCC. This cohort study...